Literature DB >> 178333

Studies on antistreptolysin O activity generated in serum by microorganisms.

K C Watson, E J Kerr.   

Abstract

An antistreptolysin factor (ASF) was generated in normal human serum by the growth of Staph, aureus and Pseud, aeruginosa. Alpha toxin producing strains of the former were usually positive but activity was not restricted to such strains. Positive strains produce cholesterol esterase which was obtained from DEAE-cellulose column fractions of 18 h broth cultures. Antistreptolysin factor develops slowly in serum, being maximal between the 5th and 10th days and is associated with alterations and disappearance of beta lipoproteins on gel electrophoresis. Activity also appeared in beta lipoproteins precipitated from normal serum with dextran sulphate and redissolved in nutrient broth before inoculation with Staph, aureus. The slow appearance of antistreptolysin activity in serum appears to be due to an esterase inhibitor which is present in high concentrations in some sera. Activity is also modified by the production of a staphylococcal fraction capable of binding to the antistreptolysin factor and reducing its activity. It is suggested that antistreptolysin factor which can be demonstrated in small amounts in normal human serum represents a readily available non-specific defence mechanism capable of binding to certain bacterial products and possible to other foreign protein molecules.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 178333      PMCID: PMC2041180     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  8 in total

1.  The inhibitory effects of cholesterol and related sterols on haemolysis by streptolysin O.

Authors:  J G HOWARD; K R WALLACE; G P WRIGHT
Journal:  Br J Exp Pathol       Date:  1953-04

2.  Nonspecific Antistreptolysin Reactions and Serum (or Pleural-Exudate) Cholesterol.

Authors:  T Packalén
Journal:  J Bacteriol       Date:  1948-08       Impact factor: 3.490

3.  Further characterization of staphylococcal gamma-hemolysin.

Authors:  A G Taylor; A W Bernheimer
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

4.  De-esterification of cholesteryl esters in human plasma alpha-lipoprotein (HDL) by preparations of staphylococcal alpha toxin.

Authors:  N R Harvie
Journal:  Biochem Biophys Res Commun       Date:  1974-12-23       Impact factor: 3.575

5.  Sterol structural requirements for inhibition of streptolysin O activity.

Authors:  K C Watson; E J Kerr
Journal:  Biochem J       Date:  1974-04       Impact factor: 3.857

6.  Generation of antistreptolysin O activity in contaminated sera.

Authors:  K C Watson; E J Kerr
Journal:  Nature       Date:  1974-07-19       Impact factor: 49.962

7.  On the geometrical arrangement of the protein subunits of human serum low-density lipoprotein: evidence for a dodecahedral model.

Authors:  H Pollard; A M Scanu; E W Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

8.  Functional role of cholesterol in infection and autoimmunity.

Authors:  K C Watson; E J Kerr
Journal:  Lancet       Date:  1975-02-08       Impact factor: 79.321

  8 in total
  2 in total

1.  Comparison of latex and haemolysin tests for determination of anti-streptolysin (ASO) antibodies.

Authors:  K C Watson; E J Kerr
Journal:  J Clin Pathol       Date:  1989-08       Impact factor: 3.411

2.  Polyene antibiotics in assessing significance of antistreptolysin O activity.

Authors:  K C Watson; E J Kerr
Journal:  J Clin Pathol       Date:  1978-03       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.